Meritage Portfolio Management Abbott Laboratories Transaction History

Meritage Portfolio Management

$1.47 Billion
Q3 2025

A detailed history of Meritage Portfolio Management transactions in Abbott Laboratories stock. As of the latest transaction made, Meritage Portfolio Management holds 4,946 shares of ABT stock, worth $643,128. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,946

Previous 4,941 0.1%

Holding current value

$643,128

Previous $672,000 1.49%

% of portfolio

0.04%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$120.51 - $136.62 $602 - $683	5 Added 0.1%	4,946 $662,000
Q2 2025 Jul 25, 2025	BUY	$123.95 - $138.08 $495 - $552	4 Added 0.08%	4,941 $672,000
Q1 2025 Apr 28, 2025	SELL	$111.1 - $140.22 $25,108 - $31,689	-226 Reduced 4.38%	4,937 $654,000
Q4 2024 Jan 27, 2025	BUY	$111.93 - $119.39 $12,536 - $13,371	112 Added 2.22%	5,163 $583,000
Q3 2024 Nov 04, 2024	BUY	$100.07 - $118.13 $4,503 - $5,315	45 Added 0.9%	5,051 $576,000
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $109,392 - $122,109	1,086 Added 27.7%	5,006 $520,000
Q1 2024 Apr 29, 2024	BUY	$109.52 - $120.96 $438 - $483	4 Added 0.1%	3,920 $446,000
Q4 2023 Feb 02, 2024	BUY	$90.19 - $110.4 $82,072 - $100,464	910 Added 30.27%	3,916 $431,000
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $7,164 - $8,596	-75 Reduced 2.43%	3,006 $291,000
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $8,465 - $9,432	84 Added 2.8%	3,081 $336,000
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $3,777 - $4,446	-39 Reduced 1.28%	2,997 $303,000
Q4 2022 Feb 01, 2023	BUY	$95.06 - $111.52 $3,612 - $4,237	38 Added 1.27%	3,036 $333,000
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $24,093 - $27,895	249 Added 9.06%	2,998 $290,000
Q2 2022 Jul 25, 2022	BUY	$102.07 - $123.37 $408 - $493	4 Added 0.15%	2,749 $299,000
Q1 2022 Apr 25, 2022	BUY	$114.02 - $139.04 $1,368 - $1,668	12 Added 0.44%	2,745 $325,000
Q4 2021 Jan 28, 2022	BUY	$115.53 - $141.46 $346 - $424	3 Added 0.11%	2,733 $385,000
Q1 2021 Apr 27, 2021	SELL	$108.84 - $128.23 $4,571 - $5,385	-42 Reduced 1.52%	2,730 $327,000
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $97,230 - $105,952	926 Added 50.16%	2,772 $304,000
Q3 2020 Oct 26, 2020	BUY	$91.64 - $111.29 $169,167 - $205,441	1,846 New	1,846 $201,000

Others Institutions Holding ABT

# of Institutions

3,649

Shares Held

1.38B

Call Options Held

10.4M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.

Account

Meritage Portfolio Management Abbott Laboratories Transaction History